Yüklüyor......
Activin A: a novel urinary biomarker of renal impairment in multiple myeloma
Renal impairment (RI) is a common complication of multiple myeloma (MM) that significantly affects treatment efficacy and mortality. However, no useful biomarkers for early detection of renal damage in MM exist. Reports indicate that activin A, a multifunctional cytokine of the TGF-β superfamily, is...
Kaydedildi:
| Yayımlandı: | Biosci Rep |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Portland Press Ltd.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6542761/ https://ncbi.nlm.nih.gov/pubmed/31072919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20190206 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|